The Fluid Management Systems Market size in Europe is predicted to be worth USD 4.19 billion by 2026 from USD 3.21 billion in 2021, registering a CAGR of 5.5% from 2021 to 2026.
Fluid management is an important part of all diagnostic and angiographic procedures. It reduces programming and installation costs. The entire workflow of a fluid management system is automated and safe. The credit of the rising interest in the fluid management devices market could be given to an expansion in the quantity of social healthcare service providers.
Some of the market's major drivers are- rise in demand for minimally invasive procedures, technological advancements in fluid management systems, government funding for healthcare, and developing healthcare infrastructure. There has been a rise in disposable incomes, which leads to the growth of the healthcare industry.
Lack of skilled surgeons and the high cost of surgical procedures are some restraints of the market.
This research report on the European Fluid Management Systems market has been segmented & sub-segmented the market into the following categories:
By Product Type:
The fluid management systems market holds the largest share in the market and covers integrated and standalone fluid management systems based on the product type. Within the fluid management systems market, the standalone fluid management systems segment accounted for the largest share of the fluid management systems market. Standalone fluid management systems are less expensive as compared to integrated systems.
By Application:
By Region:
Based on geography, Germany leads the European Fluid Management Systems market, followed by U.K and France.
Prominent companies playing a dominant role in the European Fluid Management Systems market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Ecolab, Inc. (U.S.), Zimmer Biomet Holdings Inc. (U.S.) and Cardinal Health, Inc. (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Fluid management systems
5.1.2.1 Standalone Fluid management systems
5.1.2.1.1 Dialyzers
5.1.2.1.2 Insufflators
5.1.2.1.3 Suction and irrigation systems
5.1.2.1.4 Fluid management waste systems
5.1.2.1.5 Fluid warming systems
5.1.2.1.6 Other Standalone Fluid Management Systems
5.1.2.2 Integrated Fluid Management Systems
5.1.3 Fluid management disposables and accessories
5.1.3.1 Catheters
5.1.3.2 Bloodlines
5.1.3.3 Tubing sets
5.1.3.4 Pressure monitoring lines
5.1.3.5 Pressure transducers
5.1.3.6 Valves, connectors and fittings
5.1.3.7 Suction cansiters
5.1.3.8 Cannulas
5.1.3.9 Other Fluid Management Accessories and Disposables
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Urology
5.2.3 Gastroenetrology
5.2.4 Laparoscopy
5.2.5 Gynaecology
5.2.6 Bronchoscopy
5.2.7 Arthroscopy
5.2.8 Cardiology
5.2.9 Neurology
5.2.10 Otoscopy
5.2.11 Dentistry
5.2.12 Anaesthesiology
5.2.13 Other applications
5.2.14 Y-o-Y Growth Analysis, By Application
5.2.15 Market Attractiveness Analysis, By Application
5.2.16 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co. KGaA
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Baxter International, Inc.
8.3 B. Braun Melsungen AG
8.4 Ecolab, Inc.
8.5 Zimmer Biomet Holdings Inc.
8.6 Cardinal Health, Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
